OmniAb, Inc.
NASDAQ: OABI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Matthew W. Foehr
- Employees
- 114
- Headquarters
- EmeryVille, United States
- IPO year
- 2021
- Market cap
- $271.5M
- Website
- https://www.omniab.com
Loading OABI…
Loading profile data…Frequently asked questions about OABI
What does OmniAb, Inc. (OABI) do?
OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad spectrum of antibody repertoires and advanced screening techniques, thereby facilitating the development of next-generation treatments. Central to t...
Where does OABI trade?
OmniAb, Inc. (OABI) trades on the NASDAQ Global Market.
What sector is OABI in?
OmniAb, Inc. (OABI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of OmniAb, Inc.?
Matthew W. Foehr is the chief executive officer of OmniAb, Inc. (OABI).
Where is OmniAb, Inc. headquartered?
OmniAb, Inc. is headquartered in United States.
Does OABI pay a dividend?
OmniAb, Inc. (OABI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OABI go public?
OmniAb, Inc. (OABI) completed its initial public offering in 2021.